Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long COVID ...

A new study published in Molecular Psychiatry reveals that some psychiatric disorders share genetic risk factors with ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

Secretary Kennedy's appointment led to fears that vaccine availability would be curtailed. Those fears are now being realized ...

"As temperatures rise, cancer mortality among women also rises -- particularly for ovarian and breast cancers," lead ...

Airborne microplastics and nanoplastics are increasingly detected in urban environments, with evidence linking inhalation ...

Researchers at ETH Zurich have developed the first technology that is able to recognize biomarkers in menstrual ...

What makes the news so notable is that Trump Media will use the cash to buy cryptocurrency, creating a “bitcoin Treasury” ...

AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers rega ...

About itepekimab Itepekimab is a fully human monoclonal antibody that binds to and inhibits interleukin-33 (IL33), an initiator and amplifier of broad inflammation in COPD. IL33 is thought to be ...

The harsh equation is that every 1,000 cases of measles typically result in the death or brain damage of two to three ...

VICTOR is Professor of Innovation and Public Policy at the School of Global Policy and Strategy at the University of ...